Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring
Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies
CHARBONE confirme la livraison de nouvelles commandes d'hydrogene UHP dans l'Etat de New York, un des principaux poles technologiques americains
CHARBONE Confirms the Delivery of New UHP Hydrogen Orders in New York State, One of the Main American Technology Hubs
CoTec Notes Portfolio Company HyProMag USA and Intelligent Lifecycle Solutions Commission Inserma Rare Earth Magnet Pre-Processing System in South Carolina
